Cormorant Asset Management »

Zura Bio shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Zura Bio (ZURA) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Zura Bio

Tip: Access up to 7 years of quarterly data

All positions including Zura Bio held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zura Bio by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.6M 1.5M 5.95

More positions owned by Cormorant Asset Management

Praxis Precision Medicines I Com New (PRAX)
Bridgebio Oncology Therapeut Com New (BBOT)
Eyepoint Com New (EYPT)
Edgewise Therapeutics (EWTX)
Erasca (ERAS)
Rapport Therapeutics (RAPP)
Alumis (ALMS)
Abivax Sa Sponsored Ads (ABVX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Dianthus Therapeutics (DNTH)
Bright Minds Biosciences Com New (DRUG)
Olema Pharmaceuticals (OLMA)
Bridgebio Pharma (BBIO)
Bioage Labs (BIOA)
Centessa Pharmaceuticals Sponsored Ads (CNTA)

View all positions for Cormorant Asset Management

Top funds holding Zura Bio

Suvretta Capital Management
VR Adviser
Dr. Jeffrey R. Jay, M.D.
Braidwell
Commodore Capital
Pfizer
Adage Capital Partners GP
Affinity Asset Advisors
Millennium Management
Armistice Capital
Cormorant Asset Management
QVT Financial
Siren
Ikarian Capital
EcoR1 Capital

View all funds holding Zura Bio